FOXC2 Antikörper (AA 421-501)
FOXC2
Reaktivität: Human
WB, ELISA, IHC (p), IF
Wirt: Maus
Monoclonal
2H3
unconjugated
-
-
Target
Alle FOXC2 Antikörper anzeigen
-
FOXC2
(Forkhead Box C2 (MFH-1, Mesenchyme Forkhead 1) (FOXC2))
-
Bindungsspezifität
-
AA 421-501
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Monoklonal
-
Konjugat
-
Dieser FOXC2 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)
-
Verwendungszweck
-
Mouse monoclonal antibody raised against a partial recombinant FOXC2.
-
Sequenz
-
AASWYLNHSG DLNHLPGHTF AAQQQTFPNV REMFNSHRLG IENSTLGESQ VSGNASCQLP YRSTPPLYRH AAPYSYDCTK Y
-
Kreuzreaktivität
-
Human, Ratte
-
Produktmerkmale
-
Antibody Reactive Against Recombinant Protein.
-
Immunogen
-
FOXC2 (NP_005242.1, 421 a.a. ~ 501 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Klon
-
2H3
-
Isotyp
-
IgG2b
-
Top Product
-
Discover our top product FOXC2 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Buffer
-
In 1x PBS, pH 7.4
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Imayama, Yamada, Yanamoto, Naruse, Matsushita, Takahashi, Seki, Fujita, Ikeda, Umeda: "FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma." in: Pathology oncology research : POR, Vol. 21, Issue 3, pp. 783-91, (2015) (PubMed).
Yu, Chen, Chen, Cheng, Hsu, Chang, Chen, Jan, Hsiao, Chang, Liu, Jeng, Wu, Huang, Su, Hung, Chien, Chen, Kuo, Su: "MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol." in: Oncogene, Vol. 32, Issue 4, pp. 431-43, (2013) (PubMed).
Nishida, Mimori, Yokobori, Sudo, Tanaka, Shibata, Ishii, Doki, Mori: "FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma." in: Annals of surgical oncology, Vol. 18, Issue 2, pp. 535-42, (2011) (PubMed).
-
-
Target
-
FOXC2
(Forkhead Box C2 (MFH-1, Mesenchyme Forkhead 1) (FOXC2))
-
Andere Bezeichnung
-
FOXC2 (FOXC2 Produkte)
-
Synonyme
-
FKHL14 antikoerper, LD antikoerper, MFH-1 antikoerper, MFH1 antikoerper, Fkh14 antikoerper, Hfhbf3 antikoerper, Mfh1 antikoerper, Fkhl14 antikoerper, FOXC2 antikoerper, Foxc2 antikoerper, XFD-4 antikoerper, fd-4 antikoerper, fd-4' antikoerper, fkh7 antikoerper, foxc2b antikoerper, foxc2 antikoerper, forkhead box C2 antikoerper, forkhead box C2 (MFH-1, mesenchyme forkhead 1) antikoerper, forkhead box C2 S homeolog antikoerper, forkhead box C2 L homeolog antikoerper, forkhead box protein C2 antikoerper, FOXC2 antikoerper, Foxc2 antikoerper, foxc2.S antikoerper, foxc2.L antikoerper, LOC100734751 antikoerper
-
Hintergrund
-
Full Gene Name: forkhead box C2 (MFH-1, mesenchyme forkhead 1)
Synonyms: FKHL14,LD,MFH-1,MFH1
-
Gen-ID
-
2303
-
NCBI Accession
-
NM_005251
-